BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant June 14, 2024
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration June 7, 2024
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market April 19, 2024
